ALSERES Pharmaceuticals

Alseres Pharmaceuticals is dedicated to developing diagnostic and therapeutic products for central nervous system (CNS) disorders. The company’s lead product candidate is Altropane®, a proprietary molecular imaging agent for diagnosing Parkinson's disease and dementia. Altropane is currently in Phase III clinical development for the diagnosis of Parkinson's disease. Alseres Pharmaceuticals anticipates forming one or more partnerships as part of its strategy to ensure the development and commercialization of Altropane.